Results 291 to 300 of about 4,122,734 (351)

Isotretinoin and Hidradenitis Suppurativa a Conflictual Binomial: Investigation on Differential Response Rate Between Inflammatory and Follicular Phenotype

JEADV Clinical Practice, EarlyView.
A cohort of 21 HS patients treated with isotretinoin was enrolled in this study. The main outcome was HISCR50 achievement at week 16. Overall, 2/12 patients affected by follicular phenotype of HS and 2/9 patients affected by inflammatory phenotype of HS achieved HISCR50 at week 16. No significant difference was found in response to isotretinoin between
Maria Vittoria Cannizzaro, Flaminia Antonelli, Dalma Malvaso, Federica Pellegrini, Elena Ippoliti, Niccolò Gori, Ketty Peris   +6 more
wiley   +1 more source

Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52-Week Real-World Study. [PDF]

Clin Transl Allergy
Menzella F, Cottini M, Parazzini E, Chan R, Ventura L, Mondoni M, Bosi A, Bortoli M, Senna G, Lombardi C, Corsi L, Tonin S, Rastelli A, Albrici C, Carone G, Sartor M, Piovesan TS, Marchi MR.   +17 more
europepmc   +1 more source

The Role of Artificial Intelligence in Modern Allergology: A Review of Applications in Diagnosis, Prediction, and Management

JEADV Clinical Practice, EarlyView.
ABSTRACT Artificial Intelligence is rapidly transforming allergology by enhancing diagnosis, risk prediction, automation, patient communication, education, and therapy development. Machine learning approaches, including convolutional neural networks, recurrent architectures, and transformer‐based models, enable analysis of complex datasets from ...
Sebastian Seurig, Stephan Traidl, Sonja Mathes   +2 more
wiley   +1 more source

Multidomain clinical and biological remission with tezepelumab in severe asthma: a 12-month multicentre real-world study. [PDF]

Respir Res
García-Rivero JL, Hannaoui Anaaoui A, Pallarés-Sanmartín A, Blanco-Aparicio M, García-Hernáez R, García-Gallardo Sanz V, Calvo-Álvarez U, Carazo-Fernández L, Hermida-Valverde T, Dorronsoro S, Carrascosa-Anguiano I, Lobato Astiárraga I, de Los Santos I, Enríquez-Rodríguez AI, Perez de Llano L, Álvarez Vega P, Abascal-Bolado B, Santibañez M.   +17 more
europepmc   +1 more source

DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain

JEADV Clinical Practice, EarlyView.
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau, Javier Ortiz de Frutos, Raquel Rivera‐Díaz, Lluís Puig, Jaume Notario Rosa, José Luis López‐Estebaranz, Vicente García‐Patos Briones, Ana Martín‐Santiago, José Ignacio Rojo‐Laguna, Elisabet Fernández‐Martínez, Lara Gómez‐Labrador, Esteban Daudén   +11 more
wiley   +1 more source

Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study. [PDF]

J Asthma Allergy
Montoro Ferrer A, Moro Moro MDM, Parra Borreguero FM, Moreno-Ancillo A, Extremera Ortega AM, Galindo-Bonilla PA, Jiménez Lara M, Bravo Nieto JM, Jiménez Arroyo M, Lemus Calderón JA, Espinosa de Los Monteros Garde MJ.   +10 more
europepmc   +1 more source

HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal, Emily Moon, Georgios Kallikas   +2 more
wiley   +1 more source

Global prevalence of eligibility for biologic therapy in ATS/ERS-defined severe asthma: A systematic review. [PDF]

World Allergy Organ J
Yang F, Salciccioli JD, Patel RE, McClean M, Bloom CI.   +4 more
europepmc   +1 more source

Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World Study. [PDF]

Adv Respir Med
Carriera L, Coppola A, Lipsi R, Baglioni S, Mari PV, Barone R, Ielo S, Scala R, Smargiassi A, Inchingolo R, Richeldi L, Gambacorta V, Di Giovanni A, De Corso E.   +13 more
europepmc   +1 more source

Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis. [PDF]

Allergy
Rattu A, Dixey P, Charles D, Brightling C, Chung KF, Bossios A, Bourdin A, Djukanovic R, Dahlén SE, Fleming L, Chaudhuri R, Melén E, Deschildre A, Pilette C, Koppelman GH, Exley A, Anckers F, Miller S, Nielsen H, Williams C, Khaleva E, Roberts G, 3TR consortium Respiratory Work Package.   +22 more
europepmc   +1 more source